Nvidia Reveals 9.3% Stake in AI Cloud Firm Nebius Following $2 Billion Investment 
US Dollar Holds Near One-Week High as Middle East Tensions and Oil Prices Drive Market Sentiment 
Japan Yen Slides Past 163 as Middle East Tensions Lift US Dollar, Oil Prices 
Trump Announces 100% Tariff on Generic Drug Imports Starting in 2028 
Ryanair Warns Summer Airfares May Stay Lower as Quarterly Profit Misses Estimates 
Oil Prices Extend Four-Day Rally as U.S.-Iran Conflict and Red Sea Threats Raise Supply Fears 
Belimo H1 Sales Surge as AI Data Center Cooling Drives More Than Half of Growth 
Gold Climbs Above $4,000 as Middle East Tensions and Fed Outlook Drive Safe-Haven Demand 
ASEAN Ministers Warn Middle East Conflict Threatens Regional Stability and Energy Security 
US Stock Futures Steady Ahead of Tesla, Alphabet Earnings as Iran Conflict Keeps Markets on Edge 
OpenAI Australia Data Center Switches Cooling Strategy After Recycled Water Plan Fails 
GM Q2 Earnings Beat Estimates as General Motors Raises 2026 Profit Outlook 
Domino’s Weighs Appeal After Australian Court Rules Workers Were Misled on Pay 
Australia Jobs Surge in June Strengthens Case for More RBA Rate Hikes 
KPMG Australia Appoints John Sams as CEO Following Audit Leak Scandal 
Elon Musk Fuels SpaceX-Tesla Merger Speculation After Earnings Call 
Johnson & Johnson announced it would stop selling its talc-based baby powder around the world starting next year. The New Jersey-based pharmaceutical industry company further revealed that it would be replacing the discontinued product with cornstarch-based powder.
According to CNN Business, Johnson & Johnson already halted the sale of its talc-based powder in Canada and the United States in 2020 as it has been facing thousands of lawsuits due to claims that its talcum powder caused ovarian cancer in women.
Thousands of women who have developed cancer of the ovary have sued the company. They claimed to have been using the talc-based powder regularly, and the use caused them to be afflicted with the dreaded disease.
In the lawsuits, women alleged that the asbestos in the Johnson & Johnson talcum powder causes cancer. In 2018, the jury in a St. Louis court awarded $4.7 billion to the complainants and their families. The company lost the case when the court said it was negligent and failed to warn consumers about potential health risks from the use of its baby powder.
It was noted that many other talcum powder brands had put warnings on their labels. However, Johnson & Johnson did not, and for this, it argued that such a label would be confusing. Moreover, there were scientific studies that showed an increased risk of ovarian cancer in women who use talc in their genital area, although others do not.
In any case, despite the announcement that it will no longer sell talcum powder, Johnson & Johnson still insisted that its baby powder is safe and does not cause cancer. It stated that it is still confident in the safety of the product but will be pulling them out from the market as part of a "worldwide portfolio assessment."
"We continuously evaluate and optimize our portfolio to best position the business for long-term growth," Johnson & Johnson said in a statement. "This transition will help simplify our product offerings, deliver sustainable innovation, and meet the needs of our consumers, customers and evolving global trends."
The company added, "Our position on the safety of our cosmetic talc remains unchanged and we stand firmly behind the decades of independent scientific analysis by medical experts around the world that confirms talc-based Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer."
